Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Health and Healthcare

Merck : MRK

All Merck Articles

1088 Articles

Jon C. Ogg | Oct 24, 2014 at 8:05 AM EDT

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."

Paul Ausick | Oct 13, 2014 at 4:01 PM EDT

The 4 DJIA Stocks Sank the Market

thinkstockOctober 13, 2014: Markets opened lower on Monday, a holiday for all but the equity markets. There was no economic…

Jon C. Ogg | Oct 10, 2014 at 9:30 AM EDT

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.

Paul Ausick | Oct 8, 2014 at 4:01 PM EDT

The 4 Stocks That Dominated the Market

thinkstockOctober 8, 2014: Markets opened mixed on Wednesday with virtually no economic data and little other news until the release…

Paul Ausick | Oct 3, 2014 at 4:01 PM EDT

The 4 Stocks That Boosted the Market

thinkstockOctober 3, 2014: Markets opened higher on Friday following the report on September non-farm payrolls which showed better-than-expected improvement. The…

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Jon C. Ogg | Sep 25, 2014 at 9:50 AM EDT

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.

Jon C. Ogg | Sep 24, 2014 at 6:45 AM EDT

The Best Performing DJIA Stocks of 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Lee Jackson | Sep 18, 2014 at 8:15 AM EDT

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Here are the four "Gold Standard" stocks from Credit Suisse that offer a combination of a higher yield and more…

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Paul Ausick | Sep 12, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockSeptember 12, 2014: Markets opened lower on Friday as the energy sector and utilities opened weaker. The stronger dollar weakens…

Jon C. Ogg | Sep 11, 2014 at 9:05 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data for the August 29 settlement date is out, and we have decided to look at what…

Paul Ausick | Sep 5, 2014 at 4:01 PM EDT

The 4 Stocks That Lifted the Market

thinkstockSeptember 5, 2014: Markets opened lower on Friday following a disappointing report on employment that investors later took as a…

Jon C. Ogg | Sep 4, 2014 at 4:45 PM EDT

What This Skin Cancer Drug Approval Really Means to Merck

Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.

Paul Ausick | Sep 3, 2014 at 4:01 PM EDT

The 4 Stocks That Steered the Market

thinkstockSeptember 3, 2014: Markets opened higher on Wednesday following a report — later said to be inaccurate — of a…

1 … 46 47 48 49 50 … 73

Merck : MRK

All Merck Articles

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Prediction: Poet Technologies Will Trade at This Price in 2027

New RTOO ETF Targets Robotics Supercycle Theme With 0.75% Expense Ratio

GM Just Posted Record First-Half Earnings, Recently Repurchased 35% of Its Shares, and Still Trades Below 6x Earnings

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds

Prediction: Poet Technologies Will Trade at This Price in 2027

New RTOO ETF Targets Robotics Supercycle Theme With 0.75% Expense Ratio

Merck : MRK

All Merck Articles

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Prediction: Poet Technologies Will Trade at This Price in 2027

New RTOO ETF Targets Robotics Supercycle Theme With 0.75% Expense Ratio

GM Just Posted Record First-Half Earnings, Recently Repurchased 35% of Its Shares, and Still Trades Below 6x Earnings

Featured Reads

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds